AZD-9291 (Osimertinib)
A13681-5
5mg
Brand
AdooQ BioScience
Description
AZD-9291 is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors.
Targets
|
L858R/T790M EGFR (LoVo cells) |
Exon 19 deletion EGFR (LoVo cells) |
WT EGFR (LoVo cells) |
|
11.44 nM |
12.92 nM |
493.8 nM |
Application
Reactivity
